Featured Job
-
Job Removed or Not Found
Related Jobs
- Bristol-Myers Squibb Company (Princeton, NJ)
- …will include, but are not limited to, the following: Designs and implements program-specific late development biomarker/translational plans, responsible for aiding in
- Eisai, Inc (Nutley, NJ)
- …include but are not limited to:Support the development of overall AD diagnostic strategy in medical affairsLead the development of medical education plans on AD diagnosis
- Merck & Co. (South San Francisco, CA)
- …Education:Ph.D. in computational biology or related field and a minimum of six (6) years of combined research experience in academia/pharma Required Experience and
- Merck & Co. (South San Francisco, CA)
- …certifications, experience, skills, geographic location, government requirements, and business or organizational needs.The successful candidate will be eligible for
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …Study Strategy: Provides the strategic direction to Biostatistics Data Management & Data Ops for EDC, edit checks, data quality listings, SAP, Data Management plan;
- Merck & Co. (Rahway, NJ)
- …Position Description We are seeking an experienced and skilled Cheminformatician and AI/ML data scientist to join the Cheminformatics group within Modeling and
- Genentech, Inc. (South San Francisco, CA)
- …matrix leadership and people management that meet the needs for now and in the future Creates an inclusive and inspiring scientific environment through senior leaders in
- Kymera Therapeutics (Watertown, MA)
- …Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for
- AstraZeneca (Boston, MA)
- Are you a visionary expert in translational science, with experience implementing successful strategies accelerating the development of cellular therapies for patients
- Vera Therapeutics (Brisbane, CA)
- …Title: Executive Director, Translational Research Biology Location: Brisbane, CA About Us: Vera Therapeutics (Nasdaq: VERA), is a late clinical-stage biotechnology